Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
CrossRef Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial Arashi Shahid, Xiaoqian Liu, Karen Bracken, Robin Christensen, Leticia Alle Deveza, Simone Collins, Joanna Harnett, David J
L- , L- , ,
Scientific Overview A modified 83-amino acid analog of IGF-1 with an extended half-life, studied for IGF-1 receptor binding kinetics, Akt/mTOR pathway interaction, and cellular proliferation signaling in preclinical research
Trends Anal
This not only underscores the metabolic co-option by cancer cells but also introduces a novel metabolic vulnerability that could be exploited with precision drugs
Paracetamol (acetaminophen) and the developing brain
US$ 26.45
US$ 29.31
US$ 20.91
US$ 21.35
US$ 20.15
US$ 27.87
